GSK buys full rights to make COVID, influenza vaccines from CureVac
Wednesday, July 3rd 2024, 6:25:52 am
article
The deal is the result of restructuring a collaboration, which began in 2020 to develop mRNA-based vaccines for infectious diseases, into a new licensing agreement, GSK added. As a result of the collaboration, the two companies have vaccine candidates for seasonal influenza and COVID-19 in phase II clinical development and avian influenza in phase I clinical development.
Breaking
Timesha Beauchamp, 20, was declared dead in 2020, only to wake up gasping for air at a Detroit area funeral home hours later....
Essential digital estate planning guide to protect your family's access to bank accounts, crypto, and digital memories when you're gone....
Brooklyn power-broker Frank Seddio threw another wrench into a multimillion-dollar court case now on its fifth judge — by personally phoning the latest jurist, the judge revealed Tuesday....
